Article metrics

Download PDFPDF

1527 ENB-003, an ETBR antagonist, in combination with pembrolizumab, shows promise in microsatellite stable platinum refractory/resistant ovarian cancer: data from the ENBOLDEN-101 phase 1B study

 

Online download statistics by month:

Online download statistics by month:

No statistics are available.